Sonographic markers of fetal trisomies: Second trimester

Journal of Ultrasound in Medicine

Volumn 20, Issue 6, 2001, Pages 655-674

  Nyberg, D A ^a   Souter, V L ^a  

^a NONE   (United States)

Author keywords

Choroid plexus cyst; Down syndrome; Echogenic intracardiac foci; Hyperechoic bowel; Nuchal thickening; Prenatal sonography; Pyelectasis; Trisomy 13; Trisomy 18; Trisomy 21; Ventricular dilatation

Indexed keywords

CARDIOVASCULAR SYSTEM; CHROMOSOMES; GENETIC ENGINEERING; RISK ASSESSMENT;

SONOGRAPHIC MARKERS;

ULTRASONICS;

BRAIN VENTRICLE DILATATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; ECHOGRAPHY; HUMAN; PRENATAL DIAGNOSIS; REVIEW; TRISOMY 13; TRISOMY 18; TRISOMY 21;

EID: 0034986530     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2001.20.6.655     Document Type: Review

References (149)

1. Ultrasonographically detectable markers of fetal chromosomal defects
2. Chromosome abnormalities
3. Ultrasonographically detectable markers of fetal chromosomal abnormalities
4. Prenatal sonographic findings of trisomy 18: Review of 47 cases
5. Ultrasonographic diagnosis of trisomy 18: Is it practical in the early second trimester?
6. Trisomy 13 syndrome: Prenatal US findings in a review of 33 cases
7. The sonographic detection of trisomies 13, 18, and 21
8. Enlarged cisterna magna and the Dandy-Walker malformation: Factors associated with chromosome abnormalities
9. Dandy-Walker malformation diagnosed before 21 weeks of gestation: Associated malformations and chromosomal abnormalities
10. Chromosomal abnormalities in fetuses with omphalocele: The significance of omphalocele contents
11. Abnormal karyotype of fetuses with omphalocele: Prediction based on omphalocele contents
12. Ontogeny of clenched-hand development in trisomy 18 fetuses: A serial transabdominal fetoscopic observation
13. Abnormal facial features and extremities in human trisomy syndromes: Prenatal US appearance
14. Strawberry-shaped skull in fetal trisomy 18
15. Second trimester ultrasonography may identify 77 to 97% of fetuses with trisomy 18
16. Fetal choroid plexus cysts: Are we there yet?
17. Prenatal sonographic detection of isolated fetal choroid plexus cysts: Should we screen for trisomy 18?
18. Isolated choroid plexus cysts in the second-trimester fetus: Is amniocentesis really indicated?
19. Choroid plexus cysts - Association with trisomy: Prospective review of 16,059 patients
20. Isolated fetal choroid plexus cysts and trisomy 18: A review and meta-analysis
21. Clinical significance of fetal choroid plexus cysts
22. Fetal choroid plexus cysts and trisomy 18: Assessment of risk based on ultrasound findings and maternal age
23. A sonographic karyotypic study of second-trimester fetal choroid plexus cysts
24. Sonographically detected fetal choroid plexus cysts. Frequency and association with aneuploidy
25. The significance of choroid plexus cysts in an unselected population: Results of a multicenter study
26. Isolated fetal choroid plexus cysts: Role of ultrasonography in establishment of the risk of trisomy 18
27. The second-trimester fetus with isolated choroid plexus cysts: A meta-analysis of risk of trisomies 18 and 21
28. Fetal choroid plexus cysts: An independent risk factor for chromosomal anomalies
29. Is genetic amniocentesis warranted when isolated choroid plexus cysts are found?
30. Isolated choroid plexus cysts - The need for routine offer of karyotyping
31. Fetal choroid plexus cysts: A report of 100 cases
32. Fetal choroid plexus cysts: A prospective study and review of the literature
33. Ultrasound findings and multiple marker screening in trisomy 18
34. Choroid plexus cysts: Is biochemical testing a valuable adjunct to targeted ultrasonography?
35. First-trimester diagnosis of duodenal stenosis associated with oesophageal atresia
36. Second trimester prenatal findings in duodenal and esophageal atresia without tracheoesophageal fistula
37. First-trimester diagnosis of duodenal atresia
38. Utility of minor ultrasonographic markers in the prediction of abnormal fetal karyotype at a prenatal diagnostic center
39. Isolated sonographic markers for detection of fetal down syndrome during the second trimesterq
40. Sonographic scoring index for prenatal detection of chromosomal abnormalities
41. Identification of second-trimester fetuses with autosomal trisomy by use of a sonographic scoring index
42. Trisomy 21: 91% detection rate using second-trimester ultrasound markers
43. The association between congenital heart disease and Down syndrome in prenatal life
44. Prenatal sonographic findings of Down syndrome: Review of 94 cases
45. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: Description of the method and analysis of 142 cases
46. Second-trimester ultrasound markers for detection of trisomy 21: Which markers are best?
47. Best second trimester sonographic markers for the detection of trisomy 21
48. Dysmorphologic features of the fetal pelvis in Down syndrome: Prenatal sonographic depiction and diagnostic implications of the iliac angle
49. The iliac angle as a sonographic marker for Down syndrome in second-trimester fetuses
50. Iliac angle as a marker for Down syndrome in second-trimester fetuses: CT measurement
51. Can fetal lilac bone measurement be used as a marker for Down's syndrome screening?
52. Frontal lobe shortening in second-trimester fetuses with trisomy 21: Usefulness as a US marker
53. Cerebellar and frontal lobe hypoplasia in fetuses with trisomy 21: Usefulness as combined US markers
54. Ear length in second-trimester aneuploid fetuses
55. Sonographic demonstration of hypoplasia of the middle phalanx of the fifth digit: A finding associated with Down syndrome
56. Unfused amnion and chorion after 14 weeks of gestation: Associated fetal structural and chromosomal abnormalities
57. Indication-specific accuracy of second-trimester genetic ultrasonography for the detection of trisomy 21
58. Obstetric sonography: The best way to terrify a pregnant woman
59. Ultrasound markers of fetal chromosomal abnormality: A survey of policies and practices in UK maternity ultrasound departments
60. The incorporation of maternal age into the sonographic scoring index for the detection at 14-20 weeks of fetuses with Down's syndrome
61. The "genetic sonogram": Comparison of the index scoring system with the age-adjusted US risk assessment
62. Role of prenatal ultrasound in women with positive screen for Down syndrome based on maternal serum markers
63. Abnormal biochemical serum screening versus 2nd-trimester ultrasound-detected minor anomalies as predictors of aneuploidy in low-risk patients
64. The role of ultrasonographic markers for trisomy 21 in women with positive serum biochemistry
65. Observations on an ethnic classification of idiots
66. Sonographic diagnosis of Down syndrome in the second trimester
67. Soft tissue nuchal fold in the second trimester fetus: Standards for normal measurements compared to the fetus with Down syndrome
68. Sonographic identification of second trimester fetuses with Down syndrome
69. Optimal nuchal skin-fold thresholds based on gestational age for prenatal detection of Down syndrome
70. Early midtrimester fetal nuchal thickness: Effectiveness as a marker of Down syndrome
71. Cut-off criteria for second-trimester nuchal skinfold thickness for prenatal detection of Down syndrome in a Thai population
72. New Down syndrome screening algorithm: Ultrasonographic biometry and multiple serum markers combined with maternal age
73. Gestational age standardized nuchal thickness values for estimating mid-trimester Down's syndrome risk
74. An alternative for women initially declining genetic amniocentesis: Individual Down syndrome odds on the basis of maternal age and multiple ultrasonographic markers
75. Echogenic fetal bowel during the second trimester: Clinical importance
76. Second-trimester echogenic bowel and chromosomal abnormalities
77. Is fetal hyperechogenic bowel on second-trimester sonogram an indication for amniocentesis?
78. Fetal echogenic bowel on ultrasound: Is there clinical significance?
79. Hyperechoic fetal bowel: The perinatal consequences
80. Incidence of chromosomopathies and cystic fibrosis mutations in second trimester fetuses with isolated hyperechoic bowel
81. Hyperechogenic fetal bowel: An ultrasonographic marker for adverse fetal and neonatal outcome
82. Second-trimester echogenic bowel and intraamniotic bleeding: Association between fetal bowel echogenicity and amniotic fluid spectrophotometry at 410 nm
83. Echogenic bowel and Down's syndrome
84. Effect of ultrasound transducer frequency on the appearance of the fetal bowel
85. Second-trimester echogenic small bowel: An increased risk for adverse perinatal outcome
86. Prognostic implications of fetal echogenic bowel
87. Humeral shortening in second-trimester fetuses with Down syndrome
88. Long-bone growth in fetuses with Down syndrome
89. Humerus and femur length shortening in the detection of Down's syndrome
90. Critical reappraisal of the utility of sonographic fetal femur length in the prediction of trisomy 21
91. Combining humerus and femur length for improved ultrasonographic identification of pregnancies at increased risk for trisomy 21
92. Ultrasonographically adjusted midtrimester risk of trisomy 21 and significant chromosomal defects in advanced maternal age
93. Variation in fetal femur length with respect to maternal race
94. Fetal pyelectasis: A possible association with Down syndrome
95. Fetal pyelectasis and Down syndrome: Is genetic amniocentesis warranted?
96. Fetal pyelectasis: Comparison of postnatal renal pathology with unilateral and bilateral pyelectasis
97. Isolated fetal pyelectasis: Assessment of risk for postnatal uropathy and Down syndrome
98. Effects of maternal hydration on fetal renal pyelectasis
99. Isolated fetal hydronephrosis: Beware the effect of bladder filling
100. Effect of maternal hydration on mild fetal pyelectasis
101. Effect of maternal hydration on fetal renal pyelectasis
102. Assessments of risks
103. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography
104. Fetal mild hydronephrosis and chromosomal defects: Relation to maternal age and gestation
105. A prospective study of the association between isolated fetal pyelectasis and chromosomal abnormality
106. In utero thickening of the chordae tendinae. A cause of intracardiac echogenic foci
107. The left ventricular echogenic focus: A normal finding
108. The frequency of the detection of fetal echogenic intracardiac foci with respect to maternal race
109. Fetal intracardiac echogenic foci: Does visualization depend on the orientation of the four-chamber view?
110. Natural history of echogenic foci within ventricles of the fetal heart
111. Cardiac histologic pathology characteristic of trisomies 13 and 21
112. Left ventricular echogenic focus in the fetal heart: Pathologic correlation
113. Echogenic intracardiac focus: A sonographic sign for fetal Down syndrome
114. Echogenic foci in the fetal heart: A marker of chromosomal abnormality
115. The significance of echogenic foci in the fetal heart: A prospective study of 228 cases
116. Significance of fetal intracardiac echogenic foci in relation to trisomy 21: A prospective sonographic study of high-risk pregnant women
117. Significance of an echogenic intracardiac focus in fetuses at high and low risk for aneuploidy
118. Prevalence of aneuploidy with a cardiac intraventricular echogenic focus in at-risk patient population
119. The echogenic intracardiac focus in second trimester fetuses with trisomy 21: Usefulness as a US marker
120. Prenatal ultrasonographic diagnosis of fetal heart echogenic foci: No correlation with Down syndrome
121. Prospective evaluation of the antenatal incidence and postnatal significance of the fetal echogenic cardiac focus: A case-control study
122. Small hyperechoic foci of the fetal cardiac ventricle: A benign sonographic finding?
123. The value of echogenic foci ("golfballs") in the fetal heart as a marker of chromosomal abnormalities
124. Fetal intracardiac echogenic foci: Does it matter which ventricle?
125. Unusual appearances of echogenic foci within the fetal heart: Are they benign?
126. A preliminary study of sonographic grading of fetal intracardiac echogenic foci: Feasibility, reliability, and association with aneuploidy
127. Fetal cerebral ventricular atrium: Difference in size according to sex
128. Choroid plexus-ventricular wall separation in fetuses with normal-sized cerebral ventricles at sonography: Postnatal outcome
129. Mild idiopathic lateral cerebral ventricular dilatation in utero: Sonographic evaluation
130. Mild fetal lateral cerebral ventriculomegaly: Clinical course and outcome
131. The clinical significance of fetal isolated cerebral borderline ventriculomegaly: Report of 31 cases and review of the literature
132. Isolated mild ventriculomegaly: Associated karyotypic abnormalities and in utero observations
133. Clinical outcome of mild fetal ventriculomegaly
134. Choroid plexus cysts: Not associated with Down syndrome
135. The use of color Doppler ultrasound to identify fetuses at increased risk for trisomy 21: An alternative for high-risk patients who decline genetic amniocentesis
136. The role of midtrimester targeted fetal organ screening combined with the "triple test" and maternal age in the diagnosis of trisomy 21: A retrospective study
137. The utility of fetal biometry as an adjunct to the multiple-marker screening test for Down syndrome
138. Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple-screen results
139. Prenatal detection of trisomy 21: Combined experience of two British hospitals
140. Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation
141. Prenatal screening for Down's syndrome using inhibin-A as a serum marker
142. Validation of risk estimation using the quadruple test in prenatal screening for Down syndrome
143. Comparison of urinary hyperglycosylated human chorionic gonadotropin concentration with the serum triple screen for down syndrome detection in high-risk pregnancies
144. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: A new basis for gestational Down syndrome screening
145. Urine hyperglycosylated hCG plus ultrasound biometry for detection of down syndrome in the second trimester in a high-risk population
146. Screening for fetal aneuploidy: First trimester
147. Integrated screening for Down's syndrome on the basis of tests performed during the first and second trimesters
148. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome
149. The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome